SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Examples of somatic editing include editing SCN1A mutations in Dravet syndrome or targeting EGFRvIII mutations in glioblastomas—both of which are highly promising therapeutic candidates.